Get all your news in one place.
100's of premium titles.
One app.
Start reading
Medical Daily
Medical Daily
Health
Cole Mercer

Secret Shopper Study Finds Compounded Ozempic And Zepbound Still Sold Widely After Shortages Officially Ended Last Year

What the Researchers Actually Did

More than a year after federal regulators declared the semaglutide and tirzepatide shortages over, compounded versions of the drugs behind Ozempic, Wegovy, Mounjaro and Zepbound are still being sold across storefront weight loss clinics and medical spas, according to a study published July 17 in JAMA Health Forum.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.